These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8339521

  • 1. Partial prevention of glutathione depletion in rats following acute intoxication with diethylmaleate.
    Gerard-Monnier D, Fougeat S, Gourvest JF, Chaudiére J.
    Clin Physiol Biochem; 1993; 10(1):36-42. PubMed ID: 8339521
    [Abstract] [Full Text] [Related]

  • 2. Glutathione and cysteine depletion in rats and mice following acute intoxication with diethylmaleate.
    Gerard-Monnier D, Fougeat S, Chaudiere J.
    Biochem Pharmacol; 1992 Feb 04; 43(3):451-6. PubMed ID: 1540203
    [Abstract] [Full Text] [Related]

  • 3. Effect of L-2-oxothiazolidine-4-carboxylate administration on glutathione and cysteine concentrations in guinea pig liver and kidney.
    Nishina H, Ohta J, Ubuka T.
    Physiol Chem Phys Med NMR; 1987 Feb 04; 19(1):9-13. PubMed ID: 3615644
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective modulation of glutathione in mouse brain regions and its effect on acrylamide-induced neurotoxicity.
    Shivakumar BR, Ravindranath V.
    Biochem Pharmacol; 1992 Jan 22; 43(2):263-9. PubMed ID: 1739414
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine.
    Banks MF, Stipanuk MH.
    J Nutr; 1994 Mar 22; 124(3):378-87. PubMed ID: 8120657
    [Abstract] [Full Text] [Related]

  • 11. Oxothiazolidine carboxylate provides protection against hepatocellular injury seen after porta hepatis occlusion (Pringle maneuver) under hypovolemic conditions.
    Ozgüç H, Tokyay R, Kahveci N, Serdar Z, Gur ES, Korfali E.
    World J Surg; 2003 Apr 22; 27(4):448-54. PubMed ID: 12658491
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selective glutathione repletion with oral oxothiazolidine carboxylate (OTZ) in the radiated tumor-bearing rat.
    Rose DM, Hochwald SN, Harrison LE, Burt M.
    J Surg Res; 1996 May 22; 62(2):224-8. PubMed ID: 8632643
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human.
    Porta P, Aebi S, Summer K, Lauterburg BH.
    J Pharmacol Exp Ther; 1991 Apr 22; 257(1):331-4. PubMed ID: 2019996
    [Abstract] [Full Text] [Related]

  • 17. [The correlation of tolerance to cerebral ischemia and body temperature with glutathione concentration].
    Kulinskiĭ VI, Kolesnichenko LS, Kovtun VIu, Sotnikova GV.
    Biomed Khim; 2003 Apr 22; 49(5):424-33. PubMed ID: 16119094
    [Abstract] [Full Text] [Related]

  • 18. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC, Huxtable RJ.
    Toxicol Appl Pharmacol; 1995 Jan 22; 130(1):132-9. PubMed ID: 7839360
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate.
    Williamson JM, Meister A.
    Proc Natl Acad Sci U S A; 1981 Feb 22; 78(2):936-9. PubMed ID: 6940159
    [Abstract] [Full Text] [Related]

  • 20. Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
    Moslen MT, Whitehead RF, Ferguson AE, Kanz MF.
    J Pharmacol Exp Ther; 1989 Jan 22; 248(1):157-63. PubMed ID: 2913268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.